Re: "A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion" by Wijewardene et al

Thyroid. 2023 Dec;33(12):1493-1495. doi: 10.1089/thy.2023.0258. Epub 2023 Aug 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Lung Neoplasms*
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-ret / genetics
  • Pyrazoles*
  • Pyridines

Substances

  • selpercatinib
  • Pyrazoles
  • Pyridines
  • Protein Kinase Inhibitors
  • RET protein, human
  • Proto-Oncogene Proteins c-ret